Bio-Techne Corp TECH
72.61
0.04
0.06%
as of 25 Sep
- Market cap
- $11.4B
- P/E
- 62.1×
Follow TECH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Bio-Techne Corp (TECH) Operating margin
Bio-Techne Corp's operating margin over the twelve months to 30 June 2026 was 20.7%. Over the past ten years it has ranged from 8.38% (fiscal 2025) to 32.5% (fiscal 2015); the current reading is higher than 33% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Annual
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2026 | 20.7% | 12.35 |
| FY2025 | 8.38% | (9.45) |
| FY2024 | 17.8% | (8.47) |
| FY2023 | 26.3% | (0.53) |
| FY2022 | 26.8% | 1.34 |
| FY2021 | 25.5% | 4.18 |
| FY2020 | 21.3% | 0.76 |
| FY2019 | 20.6% | (0.63) |
| FY2018 | 21.2% | (0.24) |
| FY2017 | 21.4% | (8.76) |
Quarterly
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 23.1% | (1.11) |
| Mar 2026 | 24.2% | 5.83 |
| Dec 2025 | 18.4% | 1.78 |
| Sep 2025 | 16.6% | 24.16 |
| 42 more quarters | Free account |
Against its own ten years
Low 8.38%
High 32.5%
Ten-year median
21.4%
Current reading's percentile
33
Operating margin against peers
| Company | Operating margin |
|---|---|
| KRYS Krystal Biotech, Inc. compare | 44.9% |
| HALO Halozyme Therapeutics, Inc. compare | 35.9% |
| TECH Bio-Techne Corp | 20.7% |
| BMRN BioMarin Pharmaceutical Inc. compare | 4.38% |
| CORT Corcept Therapeutics Incorporated compare | 0.77% |
| SMMT Summit Therapeutics PLC compare | 0.00% |
| AXSM Axsome Therapeutics, Inc. compare | −24.0% |
| MDGL Madrigal Pharmaceuticals, Inc. compare | −25.1% |
| BBIO BridgeBio Pharma, Inc. compare | −69.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on TECH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement